Orion Biotech Opportunities Corp.

Orion Biotech Opportunities Corp. (Nasdaq: ORIA) is a blank-check company sponsored by Orion Biotech Opportunities Management LLC, formed to pursue a business combination within the biotechnology and life sciences sector. The company completed its initial public offering in 2021 and, as reflected in the 10-Q filed with the SEC on August 12, 2021, was actively searching for a merger target at that time. ORIA focused its acquisition efforts on biopharmaceutical and medical technology companies, targeting businesses with differentiated platforms and strong development pipelines. For the complete filing history, deal timeline, and institutional data on ORIA and hundreds of other SPACs, sign up for full access at SpacDesk.